Bafna Pharmaceuticals Ltd approves Q2 FY27 results with net profit of ₹684.82 lakh, up 119.1% year on year
- Revenue was ₹4,766.56 lakh, up 34.4% year on year and 79.3% sequentially.
- Net profit compared with ₹312.49 lakh a year earlier and ₹7.51 lakh in the prior quarter; no exceptional items were reported.
- Auditor’s limited-review conclusion was unmodified, with an emphasis of matter on GST demands and recovery of prior refunds; the company has appealed the demand and secured a stay on refund recovery.
